Howard Soule

Howard Soule is a prominent figure in the field of prostate cancer research and serves as the Executive Vice President and Chief Science Officer at the Prostate Cancer Foundation (PCF).13 With a Ph.D. in his credentials, Dr. Soule has been with the foundation for over 19 years, playing a crucial role in shaping the direction of prostate cancer research.1

Professional Background

Dr. Soule's responsibilities at PCF include:

• Coordinating global academic, government, and biopharmaceutical sector research activities3
• Implementing PCF's global research strategies3
• Leading the foundation in funding and accelerating prostate cancer research globally5

Prior to his current role, Dr. Soule was the Managing Director of Knowledge Universe Health and Wellness Group, a private investment firm focused on disease prevention and treatment companies.1

Achievements and Recognition

Howard Soule's contributions to the field have been widely recognized:

• He is a member of the Department of Defense Prostate Cancer Research Program Integration Panel1
• In 2013, he received the Partners in Progress Award from the American Society of Clinical Oncology4

Impact on Prostate Cancer Research

Under Dr. Soule's leadership, PCF has made significant strides in prostate cancer research:

• The foundation has played a crucial role in laying the groundwork for medications like enzalutamide and abiraterone2
• PCF has initiated the TACTICAL (Therapy ACceleration To Intercept CAncer Lethality) campaign, which includes $3 million or more team science awards focused on new therapies for treatment-resistant prostate cancer2

Dr. Soule's work at PCF reflects the foundation's commitment to ending death and suffering from prostate cancer through innovative research and collaboration across various sectors of the scientific community.1